Skip to main content

Immunotherapy for malignant melanoma with a tumor cell vaccine.

Publication ,  Journal Article
Slingluff, CL; Seigler, HF
Published in: Ann Plast Surg
January 1992

Specific active immunotherapy for melanoma has been administered to several thousand patients since 1972, using an irradiated whole-cell preparation. A humoral response to vaccination can be demonstrated in a large percentage of patients. This response increases while immunizations are continued and decreases after cessation of therapy. The vaccinations are well tolerated; however, the therapeutic impact of this whole-cell vaccine awaits a randomized trial for definitive evaluation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Plast Surg

DOI

ISSN

0148-7043

Publication Date

January 1992

Volume

28

Issue

1

Start / End Page

104 / 107

Location

United States

Related Subject Headings

  • T-Lymphocytes, Cytotoxic
  • Survival Rate
  • Surgery
  • Skin Neoplasms
  • North Carolina
  • Neoplasm Proteins
  • Melanoma-Specific Antigens
  • Melanoma
  • Immunotherapy, Active
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Slingluff, C. L., & Seigler, H. F. (1992). Immunotherapy for malignant melanoma with a tumor cell vaccine. Ann Plast Surg, 28(1), 104–107. https://doi.org/10.1097/00000637-199201000-00026
Slingluff, C. L., and H. F. Seigler. “Immunotherapy for malignant melanoma with a tumor cell vaccine.Ann Plast Surg 28, no. 1 (January 1992): 104–7. https://doi.org/10.1097/00000637-199201000-00026.
Slingluff CL, Seigler HF. Immunotherapy for malignant melanoma with a tumor cell vaccine. Ann Plast Surg. 1992 Jan;28(1):104–7.
Slingluff, C. L., and H. F. Seigler. “Immunotherapy for malignant melanoma with a tumor cell vaccine.Ann Plast Surg, vol. 28, no. 1, Jan. 1992, pp. 104–07. Pubmed, doi:10.1097/00000637-199201000-00026.
Slingluff CL, Seigler HF. Immunotherapy for malignant melanoma with a tumor cell vaccine. Ann Plast Surg. 1992 Jan;28(1):104–107.

Published In

Ann Plast Surg

DOI

ISSN

0148-7043

Publication Date

January 1992

Volume

28

Issue

1

Start / End Page

104 / 107

Location

United States

Related Subject Headings

  • T-Lymphocytes, Cytotoxic
  • Survival Rate
  • Surgery
  • Skin Neoplasms
  • North Carolina
  • Neoplasm Proteins
  • Melanoma-Specific Antigens
  • Melanoma
  • Immunotherapy, Active
  • Humans